Tag : neurogenetic disorders

Clinical Research, Pharma & Healthcare Financing

Actio Biosciences Raises $66M Series B for Genetics-Driven Therapeutics

Business Wire
by Business Wire079
Financing co-led by Regeneron Ventures and Deerfield Management will support advancement of lead programs, ABS-1230 and ABS-0871 Phase 1 trial initiation expected in second half...
Clinical Research, Pharma & Healthcare Financing

Neurim Gets EU Approval for Slenyto® in ADHD Pediatric Insomnia

PR Newswire
by PR Newswire0126
Neurim Pharmaceuticals (“Neurim”) announces that the European Commission has approved the extension of the indication to include the treatment of insomnia in children with attention deficit...